DVAX Financial Facts
Research and development: 23.23MGeneral and administrative: 11.77M
See Full Income Statement
Accumulated deficit: -790.43M
Total current assets: 117.51M
See Full Balance Sheet
Dynavax Technologies Corp (DVAX) Earnings
|
Expand Research on DVAX
| Next EPS Date | N/A | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -474.6% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/19/26  |
Q425 | N/A | $0.04 | N/A | N/A | $79.05M | = | N/A | N/A | ||
| 11/5/25 | Q325 | $0.21 | $0.13 | +$0.08 | $94.9M | $94.41M | = |  | | Details | |
| 8/7/25 | Q225 | $0.14 | $0.10 | +$0.04 | $95.44M | $85.57M | = | | | Details | |
| 5/6/25 | Q125 | -$0.77 | $0.04 | -$0.81 | $65M | $67.86M | = | | | Details | |
| 2/20/25 | Q424 | $0.05 | $0.04 | +$0.01 | $71.1M | $72.44M | = | | | Details | |
| 11/7/24 | Q324 | $0.12 | $0.12 | $0.00 | $80.63M | $85.06M | = | | | Details | |
| 8/6/24 | Q224 | $0.08 | $0.06 | +$0.02 | $73.8M | $76.04M | = | | | Details | |
| 5/8/24 | Q124 | -$0.07 | -$0.02 | -$0.05 | $50.79M | $55.68M | = | | | Details |
